LobbyingSimtra Biopharma Solutions lobbying by quarter
Simtra Biopharma Solutions's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $100K. Its first report covers Q4 2025; the issues it reports most are Trade (Domestic & Foreign).
Simtra Biopharma Solutions
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $100K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $50K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Trade$100K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
- Treasury, Dept of1 reports
- U.S. Customs & Border Protection1 reports
- U.S. International Trade Commission (ITC)1 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Sandler, Travis & Rosenberg, P.A. | $100K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Sandler, Travis & Rosenberg, P.A. | $50K |
| 04/20for Q1 | Sandler, Travis & Rosenberg, P.A. | Under $5,000 |
| 01/20for Q4 2025 | Sandler, Travis & Rosenberg, P.A. | $50K |
| 25/12/17for Q4 2025 | Sandler, Travis & Rosenberg, P.A. | Under $5,000 |